This phase 2b trial tests a weekly oral tablet called ecnoglutide (VRB-101) for weight loss in 206 adults with obesity or overweight plus weight-related health problems. Participants receive either the drug or a placebo for several weeks. The main goal is to see how much body wei…
Phase: PHASE2 • Sponsor: Verdiva Bio Dev Limited • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC